Navigation Links
Vasogen Announces Third Quarter Conference Call and Webcast of Bio InvestorForum 2007 Presentation
Date:10/2/2007

oll-free 1-800-408-3053

----------------------------------------------------------

Pin Code 3238234 followed by the number sign

----------------------------------------------------------

Vasogen also announced today that its President and Chief Executive Officer, Chris Waddick, will present a Company overview at Bio InvestorForum 2007 on October 10, 2007, at 12:15 p.m. Pacific Time (3:15 p.m. ET) at the Palace Hotel, San Francisco. A live audio web cast and slide presentation of this event can be accessed through Vasogen's Website at: http://www.vasogen.com. An archived replay will be available following the presentation.

About Vasogen:

Vasogen is a biotechnology company engaged in the research and commercial development of therapies designed to target the destructive inflammatory process associated with the development and progression of cardiovascular and neurodegenerative disorders. The Company's lead product, the Celacade(TM) technology, is designed to activate the immune response to apoptosis - an important physiological process that regulates inflammation. Celacade is in late-stage development for the treatment of chronic heart failure and has received European regulatory approval under the CE Mark for this indication. Vasogen is also developing a new class of drugs for the treatment of certain neuro-inflammatory disorders and is preparing to advance VP025, the lead drug candidate from this new class, into phase II development.

Certain statements contained in this press release, the upcoming conference call and webcasts, or elsewhere in our public documents constitute "forward-looking statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995 and/or "forward-looking information" under the Securities Act (Ontario). These statements may include, without limitation, pl
'/>"/>

SOURCE Vasogen Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/k6lcp2/mexico_biomedical ) has announced ... - Growth, Trends & Forecasts (2014-2020)" report to ... Sensors market is estimated at $0.20 billion by 2018 ... The near future will bring biomedical sensors ... individual. These sensors can be set to trigger alerts ...
(Date:8/31/2015)... MARLBOROUGH, Mass. , Aug. 31, 2015 /PRNewswire/ ... biotechnology company focused on discovering and developing innovative ... ophthalmology, today announced that the 30-day review period ... Drug (IND) for ocular indications with the U.S. ... the IND is now active. ...
(Date:8/31/2015)... Trimb Healthcare AB ("Trimb") today announced that ... BV ("YouMedical"), a Dutch OTC company with operations in ... approximately EUR 16 million, with solid growth and leading ... is to build a leading international OTC company, and ... YouMedical gives us a stronger North European OTC platform, ...
(Date:8/30/2015)... , England , August 31, 2015 ... die 51-jährige Wartezeit   einer Frau   für chirurgische ... im Alter von 7-90   werden für ... Programm soll 1200 Frauen behandeln und die Anzahl ... Astellas gab heute bekannt, dass  ...
Breaking Biology Technology:Mexico Biomedical Sensors Market Report 2015-2020 2RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 2RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 3RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 4Über 550 Frauen, deren Leben durch "Action on Fistula" transformiert wurde 2Über 550 Frauen, deren Leben durch "Action on Fistula" transformiert wurde 3Über 550 Frauen, deren Leben durch "Action on Fistula" transformiert wurde 4Über 550 Frauen, deren Leben durch "Action on Fistula" transformiert wurde 5
... SAN JOSE, Calif., April 4, 2011 Researchers ... Institute of Bioengineering and Nanotechnology have made a ... were shown to physically detect and destroy antibiotic-resistant ... known as MRSA, while leaving healthy cells unharmed. ...
... TORONTO, April 4, 2011 Generex Biotechnology ... today the publication of a report comparing ... peptide vaccines designed for immunotherapy of breast ... developed by the Company,s wholly-owned subsidiary, Antigen ...
... CryoLife, Inc. (NYSE: CRY ), an implantable biological ... it has filed an IDE with the United ... for the purpose of obtaining Pre-Market Approval (PMA) to distribute ... or following traumatic injuries. PerClot is a ...
Cached Biology Technology:IBM and The Institute of Bioengineering and Nanotechnology Find Breakthrough for MRSA Treatment 2IBM and The Institute of Bioengineering and Nanotechnology Find Breakthrough for MRSA Treatment 3IBM and The Institute of Bioengineering and Nanotechnology Find Breakthrough for MRSA Treatment 4Generex Announces Publication of Comparative Peptide Vaccine Studies in Peer Review Journal Demonstrating Superiority of AE37 and Presentation at the American Association for Cancer Research 2Generex Announces Publication of Comparative Peptide Vaccine Studies in Peer Review Journal Demonstrating Superiority of AE37 and Presentation at the American Association for Cancer Research 3Generex Announces Publication of Comparative Peptide Vaccine Studies in Peer Review Journal Demonstrating Superiority of AE37 and Presentation at the American Association for Cancer Research 4CryoLife Files Investigational Device Exemption (IDE) to Begin Clinical Trials for PerClot® in the U.S. 2CryoLife Files Investigational Device Exemption (IDE) to Begin Clinical Trials for PerClot® in the U.S. 3CryoLife Files Investigational Device Exemption (IDE) to Begin Clinical Trials for PerClot® in the U.S. 4
(Date:8/20/2015)... 20, 2015   Sensory, Inc ., a ... user experience and security of consumer electronics through ... that its TrulySecure™ is the first ... be FIDO Certified™. The FIDO (Fast ... the FIDO UAF (Universal Authentication Framework) 1.0 specifications, ...
(Date:8/18/2015)... Aug. 18, 2015  Navitas today announced ... to the Submission Content Management webinar scheduled ... non-profit forum. Dedicated to the Implementation of Regulatory ... platform for industry, vendors, health authorities, consultants ... work towards a standard method of implementing ...
(Date:8/12/2015)... 12, 2015   MedNet Solutions , an innovative ... of clinical research, is proud to announce that ... SaaS-based eClinical technology platform, has led the way to ... quarters of 2015.   Q2 2015 and Q1 2015 ... by contract value sold in the company,s 15 year ...
Breaking Biology News(10 mins):TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 2TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 3TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 4TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 5Navitas, a Key Contributor in IRISS Forum Webinar 2Navitas, a Key Contributor in IRISS Forum Webinar 3MedNet Solutions Experiences Explosive Corporate Growth 2
... available to health officials and businesses, a Purdue University ... of melamine in infant formula. Using infrared lasers ... of food science, was able to detect melamine in ... five minutes or less. Melamine, a synthetic chemical used ...
... Mittermeier, the president of Conservation International and a global ... Peterson Medal from the Harvard Museum of Natural History. ... strategist who has written more than 500 scientific and ... He has described 11 species new to science, had ...
... cancer researchers at The Ohio State University has ... certain proteins that may make good biomarkers in ... liquid chromatography-mass spectrometry (LC-MS) can measure variations in ... and store DNA. The technology accurately detected differences ...
Cached Biology News:Researcher: Lasers used to detect melamine in baby formula 2Study validates means to measure possible leukemia marker 2
... The Captivate magnetic ... can be used in conjunction ... (C-21473, C-21474, C-21476) or other ... with most 96-well microplates. Cell ...
Protein Phosphorylation...
...
The Light Diagnostics Calicivirus Genotype 1&2 Typing OligoDetect assay is applicable for the qualitative detection of calicivirus RNA generated by an in-house validated in vitro nucleic acid amplifi...
Biology Products: